Getinge AB (GETIb.ST)
Sept 2 - Getinge CEO Alex Myers presenting at company's Capital Markets Day:
STOCKHOLM, Sept 2 - Swedish medical technology group Getinge mapped out a new restructuring plan on Wednesday aimed at boosting growth and efficiency, and set fresh financial targets, sending shares higher.
* Sees no additional restructuring costs relating to FDA consent decree charged after 2015-presentation material
* Getinge to strengthen competitiveness with a comprehensive transformation program focused on growth, efficiency and a new organization
* Getinge ceo says financial guidance ahead likely to focus more on sales, profit growth, not on margins
* CEO says sees constant price pressure of a couple of percent Further company coverage:
* Q1 EBITA 717 mln SEK vs forecast 835 mln (Adds detail, background)
STOCKHOLM, April 20 - Swedish medical technology group Getinge posted a first-quarter core profit below analyst forecasts on Monday and stood by its outlook for better growth in 2015.
Earnings vs. Estimates
Analyst Research Reports
Provider : Wright Reports
Provider : Sadif Analytics Prime
Getinge AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : GlobalData
Provider : Thomson Reuters StreetEvents
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.